News and Announcements
‘Next Cochlear’ 4Dx Closes Capital Raise as FDA Approval Enters Sight
- Published November 21, 2016 4:24PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st November 2016, AFR Yolanda Redrup
The company, which already has one major deal with Los Angeles hospital Cedars Sinai to use its lung imaging technology, also has an additional $2.5 million committed that is expected to close this week, taking its total series A raise to more than $5 million.
Chief executive Andreas Fouras said the company had developed a strong investor base featuring healthcare professionals and business bigwigs from retail, resources and banking and finance, making him confident the company could go achieve its ambitions of being as successful as Cochlear.
“These investors are just dipping their toes in the water at the moment with us, so that makes me excited about what it means for their ability to take a stronger position going forward when we release strong results next year,” he said.
To view the full announcement, please click on the button below.